VACCINE ESCAPE OF VARIANTS vs Pfizer-BioNTech & NIH-Moderna

Troubling new peer-reviewed paper shows even 2-dose recipients have serious trouble neutralizing the #B1351 🇿🇦 variant—as little as vs old SARS & bat coronavirus. #P1 is poor too. 1-dose worse. Lots of graphs

VACCINE ESCAPE OF VARIANTS vs Pfizer-BioNTech & NIH-Moderna: Troubling new peer-reviewed paper shows even 2-dose recipients have serious trouble neutralizing the #B1351 🇿🇦 variant—as little as vs old SARS & bat coronavirus. #P1 is poor too. 1-dose worse. Lots of graphs🧵 」同氏 https://t.co/WE9ARNRYyy pic.twitter.com/DU5AIrhEyy

— 原口　一博 (@kharaguchi) March 23, 2021